Skip to search.
 STI Down0.09%

Cardiome Pharma Corp. (CRME)

-NasdaqCM

2.15 Up 0.03(1.42%) 18 May 03:51 SGT

Add to Portfolio
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):3.2
Mean Recommendation (last week):3.2
Change:0.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:3.39
Median Target:2.50
High Target:6.25
Low Target:0.75
No. of Brokers:5

Data provided by Thomson/First Call
Upgrades & Downgrades History
DateResearch FirmActionFromTo
Apr 27, 2011RBC Capital MktsUpgradeSector PerformOutperform
Dec 8, 2010WedbushInitiated Outperform
Jul 16, 2008RBC Capital MktsDowngradeOutperformSector Perform
Mar 20, 2008WachoviaInitiated Outperform
Mar 11, 2008BMO Capital MarketsInitiated Market Perform
Oct 9, 2007Lehman BrothersInitiated Equal-weight
Feb 23, 2007Bear StearnsInitiated Outperform
Mar 23, 2006HSBC SecuritiesDowngradeNeutralUnderweight
Sep 23, 2005Rodman & RenshawInitiated Mkt Outperform
Jul 1, 2005Leerink SwannInitiated Outperform
Data provided by Briefing.com

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0000
Buy0000
Hold0443
Underperform0111
Sell0000

Data provided by Thomson/First Call


Currency in USD.